Analyses of multidrug efflux pump-like proteins encoded on the Staphylococcus aureus chromosome

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 1, 2015, Pages 747-748

  Schindler, Bryan D ^a   Frempong Manso, Emmanuel ^b   DeMarco, Carmen E ^b   Kosmidis, Christos ^b   Matta, Varun ^a   Seo, Susan M ^a   Kaatz, Glenn W ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIFLAVINE; BACTERIAL PROTEIN; BENZALKONIUM CHLORIDE; BERBERINE; CETRIMIDE; CHLORAMPHENICOL; CHLORHEXIDINE; CRYSTAL VIOLET; DEQUALINIUM; DODECYL SULFATE SODIUM; ETHIDIUM BROMIDE; FUSIDIC ACID; GENTAMICIN; HOE 33342; LINCOMYCIN; LINEZOLID; MULTIDRUG RESISTANCE PROTEIN; NORFLOXACIN; PENTAMIDINE; PYRONINE; RHODAMINE 6G; TEICOPLANIN; TETRACYCLINE; TETRAPHENYLPHOSPHONIUM; ANTIINFECTIVE AGENT;

BACTERIAL CHROMOSOME; BACTERIAL GENOME; BROTH DILUTION; GENE EXPRESSION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NOTE; STAPHYLOCOCCUS AUREUS; GENE; GENETICS; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE; OPEN READING FRAME;

ANTI-BACTERIAL AGENTS; CHROMOSOMES, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, MDR; MICROBIAL SENSITIVITY TESTS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; OPEN READING FRAMES; STAPHYLOCOCCUS AUREUS;

EID: 84920195962     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.04678-14     Document Type: Note

References (19)

1. Weber DJ, Anderson D, Rutala WA. 2013. The role of the surface environment in healthcare-associated infections. Curr Opin Infect Dis 26:338-344. http://dx.doi.org/10.1097/QCO.0b013e3283630f04.
2. Markham PN, Neyfakh AA. 1996. Inhibition of the multidrug transporter NorA prevents emergence of norfloxacin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 40:2673-2674.
3. B modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4. J Bacteriol 184:5457-5467. http://dx.doi.org/10.1128/JB .184.19.5457-5467.2002.
4. Bateman BT, Donegan NP, Jarry TM, Palma M, Cheung AL. 2001. Evaluation of a tetracycline-inducible promoter in Staphylococcus aureus in vitro and in vivo and its application in demonstrating the role of sigB in microcolony formation. Infect Immun 69:7851-7857. http://dx.doi.org /10.1128/IAI.69.12.7851-7857.2001.
5. Foster TJ. 1998. Molecular genetic analysis of staphylococcal virulence. Methods Microbiol 27:433-454. http://dx.doi.org/10.1016/S0580-9517 (08)70303-9.
6. Kaatz GW, Thyagarajan RV, Seo SM. 2005. Effect of promoter region mutations and mgrA overexpression on transcription of norA, which encodes a Staphylococcus aureus multidrug efflux transporter. Antimicrob Agents Chemother 49:161-169. http://dx.doi.org/10.1128/AAC.49.1.161 -169.2005.
7. th ed. Approved standard M7-A7. Clinical and Laboratory Standards Institute, Wayne PA.
8. Huang J, O'Toole PW, Shen W, Amrine-Madsen H, Jiang X, Lobo N, Palmer LM, Voelker L, Fan F, Gwynn MN, McDevitt D. 2004. Novel chromosomally encoded multidrug efflux transporter MdeA in Staphylococcus aureus. Antimicrob Agents Chemother 48:909-917. http://dx.doi .org/10.1128/AAC.48.3.909-917.2004.
9. Kaatz GW, McAleese F, Seo SM. 2005. Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein. Antimicrob Agents Chemother 49: 1857-1864. http://dx.doi.org/10.1128/AAC.49.5.1857-1864.2005.
10. Kaatz GW, Seo SM, Ruble CA. 1991. Mechanisms of fluoroquinolone resistance in Staphylococcus aureus. J Infect Dis 163:1080-1086. http://dx .doi.org/10.1093/infdis/163.5.1080.
11. Truong-Bolduc QC, Dunman PM, Strahilevitz J, Projan SJ, Hooper DC. 2005. MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus. J Bacteriol 187:2395-2405. http://dx.doi.org/10.1128/JB .187.7.2395-2405.2005.
12. Truong-Bolduc QC, Strahilevitz J, Hooper DC. 2006. NorC, a new efflux pump regulated byMgrAof Staphylococcus aureus. Antimicrob Agents Chemother 50:1104-1107. http://dx.doi.org/10.1128/AAC.50.3.1104-1107.2006.
13. Yoshida H, Bogaki M, Nakamura S, Ubukata K, Konno M. 1990. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J Bacteriol 172:6942-6949.
14. Kaatz GW, Seo SM, Ruble CA. 1993. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. Antimicrob Agents Chemother 37: 1086-1094. http://dx.doi.org/10.1128/AAC.37.5.1086.
15. Floyd JL, Smith KP, Kumar SH, Floyd JT, Varela MF. 2010. LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus. Antimicrob Agents Chemother 54:5406-5412. http://dx .doi.org/10.1128/AAC.00580-10.
16. Narui K, Noguchi N, Wakasugi K, Sasatsu M. 2002. Cloning and characterization of a novel chromosomal drug efflux gene in Staphylococcus aureus. Biol Pharm Bull 25:1533-1536. http://dx.doi.org/10.1248/bpb.25.1533.
17. Yamada Y, Hideka K, Shiota S, Kuroda T, Tsuchiya T. 2006. Gene cloning and characterization of SdrM, a chromosomally-encoded multidrug efflux pump, from Staphylococcus aureus. Biol Pharm Bull 29:554-556. http://dx.doi.org/10.1248/bpb.29.554.
18. Ding Y, Fu Y, Lee JC, Hooper DC. 2012. Staphylococcus aureus NorD, a putative efflux pump coregulated with the Opp1 oligopeptide permease, contributes selectively to fitness in vivo. J Bacteriol 194:6586-6593. http: //dx.doi.org/10.1128/JB.01414-12.
19. Domenech P, Reed MB, Barry CE, III. 2005. Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance. Infect Immun 73:3492-3501. http://dx.doi.org/10.1128/IAI.73.6 .3492-3501.2005.